Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Small molecule
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Molecular weight cutoff == The upper [[Molecular mass|molecular-weight]] limit for a small molecule is approximately 900 daltons, which allows for the possibility to rapidly diffuse across cell membranes so that it can reach [[intracellular]] sites of action.<ref name = "Dougherty_Pucci_2012"/><ref name="pmid12036371">{{cite journal |vauthors=Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD | title = Molecular properties that influence the oral bioavailability of drug candidates | journal = J. Med. Chem. | volume = 45 | issue = 12 | pages = 2615β23 |date=June 2002 | pmid = 12036371 | doi = 10.1021/jm020017n | citeseerx = 10.1.1.606.5270 }}</ref> This molecular weight cutoff is also a necessary but insufficient condition for oral [[bioavailability]] as it allows for [[transcellular transport]] through intestinal [[epithelial]] cells. In addition to intestinal permeability, the molecule must also possess a reasonably rapid [[Dissolution (chemistry)#Rate of dissolution|rate of dissolution]] into water and adequate water [[solubility]] and moderate to low [[first pass metabolism]]. A somewhat lower molecular weight cutoff of 500 daltons (as part of the "[[rule of five]]") has been recommended for oral small molecule drug candidates based on the observation that clinical attrition rates are significantly reduced if the molecular weight is kept below this limit.<ref>{{cite journal | author = Lipinski CA | title = Lead-and drug-like compounds: the rule-of-five revolution | journal = Drug Discovery Today: Technologies |date=December 2004 | volume = 1 | issue = 4 | pages = 337β341 | doi = 10.1016/j.ddtec.2004.11.007 | pmid = 24981612 }}</ref><ref name="pmid17971784">{{cite journal |vauthors=Leeson PD, Springthorpe B | title = The influence of drug-like concepts on decision-making in medicinal chemistry | journal = Nature Reviews Drug Discovery | volume = 6 | issue = 11 | pages = 881β90 |date=November 2007 | pmid = 17971784 | doi = 10.1038/nrd2445 | s2cid = 205476574 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)